South Street Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-112,384
Closed -$9.02K 64
2018
Q1
$9.02K Hold
112,384
0.89% 19
2017
Q4
$9.07M Buy
112,384
+75
+0.1% +$6.01K 2.75% 19
2017
Q3
$8.73K Sell
112,309
-200
-0.2% -$16.6K 1.69% 19
2017
Q2
$9.98M Buy
112,509
+99,550
+768% +$8.39M 3.27% 14
2017
Q1
$9.1K Sell
12,959
-99,630
-88% -$7.78M 1.25% 20
2016
Q4
$8.02M Sell
112,589
-29,101
-21% -$2.29M 2.83% 20
2016
Q3
$12.2M Sell
141,690
-10,514
-7% -$916K 3.78% 8
2016
Q2
$13.2M Sell
152,204
-1,830
-1% -$148K 4.15% 8
2016
Q1
$11.6M Buy
154,034
+1,150
+0.8% +$86.6K 3.82% 13
2015
Q4
$11.8M Buy
152,884
+3,006
+2% +$226K 3.76% 10
2015
Q3
$10M Buy
149,878
+4,225
+3% +$311K 3.39% 11
2015
Q2
$10.8M Buy
145,653
+4,720
+3% +$361K 3.39% 11
2015
Q1
$11K Buy
+140,933
New +$10.7M 3.25% 11

Other funds holding MDT

South Street Advisors's MDT Position: Q2 2018 in Review

South Street Advisors sold out of Medtronic (MDT) in Q2 2018, closing a stake of 112,384 shares — an estimated $9.02K sold.

South Street Advisors first reported a position in MDT in Q1 2015 and held it in 13 quarters. The position peaked at $13.2M in Q2 2016. 1,410 funds tracked by Wall St. Rank hold MDT as of Q2 2018.

  • South Street Advisors reported no remaining Medtronic position as of Q2 2018 after selling out during the quarter.
  • South Street Advisors sold 112,384 Medtronic shares in Q2 2018, an estimated $9.02K.
  • South Street Advisors first reported a position in Medtronic in Q1 2015 and held it in 13 quarters.
  • South Street Advisors's Medtronic position peaked at $13.2M in Q2 2016.
  • 1,410 funds tracked by Wall St. Rank held Medtronic as of Q2 2018.

Based on South Street Advisors's 13F filing for Q2 2018, filed 15 Aug 2018.